• Fate Therapeutics, Inc. (NASDAQ:FATE) Receives Average Rating of "Hold" from Analysts

    来源: Buzz FX / 14 10月 2024 04:16:11   America/Chicago


    Fate Therapeutics, Inc. (NASDAQ:FATE) Receives Average Rating of "Hold" from Analysts Written by MarketBeat October 14, 2024 Share Link copied to clipboard. Shares of Fate Therapeutics, Inc. ( NASDAQ:FATE - Get Free Report ) have been given
    Read more...
分享